0001209191-21-020164.txt : 20210312
0001209191-21-020164.hdr.sgml : 20210312
20210312162805
ACCESSION NUMBER: 0001209191-21-020164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200423
FILED AS OF DATE: 20210312
DATE AS OF CHANGE: 20210312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Polovets Stanislav
CENTRAL INDEX KEY: 0001847625
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38807
FILM NUMBER: 21737796
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 1400E, SUITE 14-105
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anchiano Therapeutics Ltd.
CENTRAL INDEX KEY: 0001534248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 KIRYAT HAMADA ST
STREET 2: PO BOX 45032
CITY: JERUSALEM
STATE: L3
ZIP: 9777401
BUSINESS PHONE: 972-2-5486555
MAIL ADDRESS:
STREET 1: 5 KIRYAT HAMADA ST
STREET 2: PO BOX 45032
CITY: JERUSALEM
STATE: L3
ZIP: 9777401
FORMER COMPANY:
FORMER CONFORMED NAME: BioCancell Ltd.
DATE OF NAME CHANGE: 20111104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-23
0
0001534248
Anchiano Therapeutics Ltd.
ANCN
0001847625
Polovets Stanislav
ONE KENDALL SQUARE, BUILDING 1400E
SUITE 14-105
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
0.17
2020-07-16
4
A
0
55000
0.00
A
2030-07-15
Ordinary Shares
55000
55000
D
25% of shares underlying the option vests on July 16, 2021, and 12.5% of the remaining shares underlying the option vest in eight equal quarterly installments thereafter.
/s/ Jason Minio, Attorney-in-Fact
2021-03-12